Carrageenan-Induced Inflammatory Pain
CFA Induced Inflammatory Pain
Chemotherapy-Induced Neuropathic Pain
Chronic Post-Ischemia Pain
Collagen-Induced Arthritis
EAE
MIA Induced Osteoarthritis
Neurite Outgrowth Assay
Neurodegeneration Screening Assay
Neuroma
Symptomatic Neuroma
Parkinson's Disease
Peripheral Nerve Injury
Peripheral Nerve Repair
Neuropathic Pain
Post-Operative Pain
Spinal Cord Injury
Stroke and Ischemia
STZ-Induced Diabetic Neuropathic Pain
Wound Healing
Cortical Trauma Injury Model
ZDF Model
Cuprizone Model
Oct 27, 2026by MD Biosciences
Pain is a principal presenting symptom of rheumatoid arthritis, and persistent pain despite low inflammatory activity...
Oct 20, 2026by MD Biosciences
The clinical value of a non-opioid analgesic is defined relative to the established agents it is intended to replace,...
Oct 13, 2026by MD Biosciences
Multiple sclerosis therapy has been transformed by agents that control inflammation, and the unmet need has shifted...
Oct 6, 2026by MD Biosciences
The FDA issued draft guidance on the development of non-opioid analgesics for acute pain in 2022, covering development...
Sep 29, 2026by MD Biosciences
The GLP-1 receptor agonists have changed the trajectory of type 2 diabetes care, and the evidence now suggests their...
.png?width=317&height=317&name=Kidney%20Injury%20Image%20(2).png)
.png?width=600&height=600&name=Nerve%20injury%20datasheet%20(1).png)
.png?width=600&height=600&name=Wound%20Healing%20datasheet%20(1).png)
